Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,171Revenue (TTM) $M2,105Net Margin (%)8.7Altman Z-Score3.8
Enterprise Value $M6,789EPS (TTM) $1.1Operating Margin %16.7Piotroski F-Score6
P/E(ttm)32.8Beneish M-Score-1.8Pre-tax Margin (%)10.6Higher ROA y-yN
Price/Book3.310-y EBITDA Growth Rate %27.2Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %17.7Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-30.1ROA % (ttm)5.8Higher Current Ratio y-yN
Dividend Yield %0.8PEG2.1ROE % (ttm)10.2Less Shares Outstanding y-yY
Payout Ratio %35.0Shares Outstanding M166ROIC % (ttm)12.6Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

RDY is held by these investors:



RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about RDY:

    News about RDY:

    Articles On GuruFocus.com
    Agios and Aurigene Enter into Exclusive License Agreement for Novel Small Molecules for Cancer Metab Apr 27 2017 
    Stocks Reach Their 3-Year Lows Mar 25 2017 
    Growing Generic Drug Market a Good Opportuity for 2 India Firms May 30 2016 
    Ken Fisher Sells Shares of PMC Sierra, Alphabet During 4th Quarter Jan 15 2016 
    Emerging Market Stocks To Watch Out For Feb 17 2015 
    Should You Buy Actavis? Mar 18 2014 
    Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
    5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
    Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 

    More From Other Websites
    Xgeva Is Expected to See Robust Revenue Performance in 2017 May 24 2017
    Elite Pharmaceuticals Acquires Trimipramine ANDA May 22 2017
    Dr. Reddy's Laboratories Announces USFDA Approval for the Launch of Doxorubicin Hydrochloride... May 17 2017
    Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q4 May 15 2017
    Doctor Reddy's posts 4Q profit May 12 2017
    Dr. Reddy’s Q4 and FY17 Financial Results May 12 2017
    Agios and Aurigene Enter into Exclusive License Agreement for Novel Small Molecules for Cancer... Apr 27 2017
    Dr. Reddy's Laboratories Announces the Launch of Ezetimibe and Simvastatin Tablets in the U.S.... Apr 27 2017
    Dr. Reddy's Laboratories Announces the Launch of Progesterone Capsules in the U.S. Market Apr 21 2017
    New Strong Sell Stocks for April 20th Apr 20 2017
    India's Dr Reddy's says U.S. FDA raises fresh concerns at Srikakulam drug plant Apr 04 2017
    Dr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and Distribute DuraGen... Mar 27 2017
    Stocks Reach Their 3-Year Lows Mar 25 2017
    CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories Mar 16 2017
    Dr. Reddy's Expands Commercial Operations in Europe Feb 08 2017
    BioMarin sues to stop generic version of its $90K-a-year drug Feb 07 2017
    Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q3, 2017 By the Numbers : February 7,... Feb 07 2017
    Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q3 Feb 06 2017
    Dr. Reddy’s Q3 and 9M FY17 Financial Results Feb 04 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)